Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia

海西定 汉普 铁转运蛋白 慢性病贫血 生物 贫血 RNA干扰 转铁蛋白 转铁蛋白饱和度 小干扰RNA 细胞生物学 内分泌学 内科学 医学 转染 缺铁 核糖核酸 生物化学 基因
作者
Akin Akinc,Amy Chan-Daniels,Alfica Sehgal,Don Foster,Brian R. Bettencourt,Julia Hettinger,Tim Racie,Justin Aubin,Satya Kuchimanchi,Hila Epstein-Barash,Tomoko Nakayama
出处
期刊:Blood [Elsevier BV]
卷期号:118 (21): 688-688 被引量:24
标识
DOI:10.1182/blood.v118.21.688.688
摘要

Abstract Abstract 688 Hepcidin, a liver-expressed peptide hormone, plays a central role in iron homeostasis by regulating the level of ferroportin. Ferroportin, the only known mammalian cellular iron exporter, is found on enterocytes, hepatocytes, and macrophages and allows the flux of iron from these cells into plasma. Upon binding, hepcidin induces the internalization and degradation of ferroportin, thereby modulating the absorption of iron from the diet and release of iron from cellular stores. Inappropriate hepcidin levels can therefore lead to dysregulation of iron homeostasis. In particular, inappropriately elevated hepcidin levels can limit iron needed for heme production, resulting in anemia. Elevated hepcidin is thought to play an important role in anemia of chronic disease and anemia of chronic kidney disease. RNA interference (RNAi) is a fundamental cellular mechanism for silencing genes and other transcribed elements, including those currently “undruggable” by small molecule and antibody therapeutics. RNAi has already transformed biological research by serving as a powerful tool for studying gene function and is now poised to form the basis of a new class of therapeutics. Small interfering RNAs (siRNAs) were developed against HAMP, the hepcidin gene, as well as other targets involved in iron metabolism (including HJV, TFR2, HFE, Neogenin, BMP6, BMPRI, BMPRII, SMAD4, and IL6R), both as a means to identify a therapeutic for the treatment of anemia and as a means to further characterize the hepcidin signaling pathway. Hepcidin was effectively silenced in mice, rats, and nonhuman primates, resulting in concomitant dose-dependent increases in serum iron, with approximately 100% transferrin saturation achievable after a single administration. Treatment with HAMP-targeting siRNA was able to blunt hepcidin induction, hypoferremia, and the onset of anemia in a turpentine-induced mouse model of inflammatory anemia. Silencing other members of the hepcidin pathway resulted in decreases in HAMP expression and increases in transferrin saturation to varying degrees. In particular, TFR2 was found to be an especially attractive target, leading to potent downregulation of HAMP, and rapid and durable increases in transferrin saturation. A single 0.1 mg/kg dose of a TFR2-targeting siRNA, resulted in ∼80% silencing of both TFR2 and HAMP and 100% transferrin saturation within 24 hours post-administration in mice. HAMP silencing and elevated transferrin saturation persisted for over two weeks, with levels returning to baseline after 4 weeks. In addition, TFR2 targeting resulted in the resolution of anemia in rodent models of anemia of inflammation. These data indicate that siRNAs directed at HAMP, TFR2, and other members of the hepcidin pathway represent an attractive novel therapeutic approach for the treatment of anemia of chronic disease and anemia of chronic renal disease. Disclosures: Akinc: Alnylam Pharmaceuticals: Employment. Chan-Daniels:Alnylam Pharmaceuticals: Employment. Sehgal:Alnylam Pharmaceuticals: Employment. Foster:Alnylam Pharmaceuticals: Employment. Bettencourt:Alnylam Pharmaceuticals, Inc.: Employment. Hettinger:Alnylam Pharmaceuticals, Inc.: Employment. Racie:Alnylam Pharmaceuticals, Inc.: Employment. Aubin:Alnylam Pharmaceuticals: Employment. Kuchimanchi:Alnylam Pharmaceuticals: Employment. Epstein-Barash:Alnylam Pharmaceuticals: Employment. Nakayama:Alnylam Pharmaceuticals: Employment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无花果应助annoying采纳,获得10
刚刚
MW_Zitie发布了新的文献求助10
刚刚
1秒前
zl发布了新的文献求助10
1秒前
1秒前
1秒前
苦命吗喽完成签到,获得积分10
2秒前
2秒前
赵赵赵发布了新的文献求助30
2秒前
dreamboat完成签到,获得积分10
3秒前
高兴问凝发布了新的文献求助10
3秒前
科研通AI5应助cmx采纳,获得10
5秒前
6秒前
Kinesin发布了新的文献求助10
7秒前
浅尝离白给上上下下的求助进行了留言
7秒前
金刚大王完成签到,获得积分10
7秒前
wanci应助zl采纳,获得10
8秒前
77seven发布了新的文献求助10
8秒前
LIU完成签到,获得积分10
8秒前
Grey完成签到 ,获得积分10
8秒前
小真白完成签到,获得积分10
10秒前
10秒前
聪明仰完成签到 ,获得积分10
10秒前
cdercder应助LIU采纳,获得10
11秒前
Nancy完成签到,获得积分10
13秒前
13秒前
万能图书馆应助乐观黑米采纳,获得10
14秒前
yammy关注了科研通微信公众号
15秒前
weige完成签到,获得积分10
16秒前
18秒前
超锅发布了新的文献求助10
18秒前
拉长的大侠完成签到 ,获得积分10
18秒前
19秒前
22秒前
ding应助ZZ采纳,获得10
22秒前
十七完成签到,获得积分20
22秒前
net80yhm完成签到,获得积分10
22秒前
23秒前
23秒前
Owen应助啊盘采纳,获得10
23秒前
高分求助中
Mass producing individuality 600
Разработка метода ускоренного контроля качества электрохромных устройств 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
A Combined Chronic Toxicity and Carcinogenicity Study of ε-Polylysine in the Rat 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3824207
求助须知:如何正确求助?哪些是违规求助? 3366533
关于积分的说明 10441059
捐赠科研通 3085772
什么是DOI,文献DOI怎么找? 1697543
邀请新用户注册赠送积分活动 816398
科研通“疑难数据库(出版商)”最低求助积分说明 769611